IFNB1
-
Official Full Name
interferon, beta 1, fibroblast
-
Overview
Has antiviral, antibacterial and anticancer activities. -
Synonyms
IFNB1; interferon, beta 1, fibroblast; IFB; IFF; IFNB; interferon beta; IFN-beta; fibroblast interferon;
- Recombinant Proteins
- Cell & Tissue Lysates
- Transfected Stable Cell Lines
- Therapeutic Proteins
- Protein Pre-coupled Magnetic Beads
- Cattle
- Chicken
- Cynomolgus Monkey
- Dog
- Equine
- Horse
- Human
- Mouse
- Pig
- Rabbit
- Rat
- Rhesus
- Rhesus Macaque
- Rhesus monkey
- CHO
- E. coli
- E.coli
- Fibroblast
- HEK293
- HEK293F
- Human
- Human Cell
- Mammalian Cell
- Pseudomonas Fluorescens
- Yeast
- C
- His
- Fc
- GST
- His (Fc)
- Avi
- His(C
- ter)
- His|GST
- mFc
- N/A
- N
- Involved Pathway
- Protein Function
- Interacting Protein
- IFNB1 Related Gene Family
- IFNB1 Related Research Area
- IFNB1 Related Signal Pathway
IFNB1 involved in several pathways and played different roles in them. We selected most pathways IFNB1 participated on our site, such as Cytokine-cytokine receptor interaction, PIK-Akt signaling pathway, Osteoclast differentiation, which may be useful for your reference. Also, other proteins which involved in the same pathway with IFNB1 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|---|
| Cytokine-cytokine receptor interaction | EPOR;BMP7A;ACVR1L;BMP7;CXCL14;IL20RB;CD40LG;TNFRSF11B;Ccl27a |
| PIK-Akt signaling pathway | MAP2K2;GNGT1;RPTOR;ITGA5;PPP2R2B;NRAS;FGF5;PPP2R5C;ITGB1 |
| Osteoclast differentiation | AKT1;GAB2;NFKBIA;BLNK;IFNAR2;LILRA1;cgr2b;LILRB3;MAPK13 |
| Toll-like receptor signaling pathway | TBK1;MAP2K1;IFNA5;MAPK3;CCL5;IFNPHI3;CXCL8B.3;PIK3R2;MYD88 |
| RIG-I-like receptor signaling pathway | TRADD;MAPK11;IFNA8;MAP3K7;MAPK14A;IFNPHI3;IFNA2;OTUD5A;OTUD5 |
| Cytosolic DNA-sensing pathway | TMEM173;IL18;CCL4L1;CCL4L2;NFKB1;IL6;NFKBIAB;IRF3;POLR3G |
| Jak-STAT signaling pathway | Ifnl2;GH2;IL28A;PTPN11A;SOS1;IFNB;CSF3R;CCND2A;EPO |
| Natural killer cell mediated cytotoxicity | NFATC1;PIK3CA;MAP2K1;IFNAR2;KIR2DS2;TNFRSF10A;MAPK1;IFNA6;CD48 |
| Chagas disease (American trypanosomiasis) | GNAS;PIK3R3;PPP2R2A;LOC100033925;PPP2CB;CD3G;IL10;TRAF6;GNAI3 |
| Tuberculosis | NFYB;TLR9;CASP9;MAPK3;IFNA17;HLA-DMA;ATP6V0B;HLA-DPB1;CALM1 |
| Hepatitis C | CLDN8;IFN-a;EIF2AK4;MAVS;GSK3B;OAS2;IFNA8;RIPK1;CLDN3 |
| Hepatitis B | STAT5B;MAPK1;IL6;PTEN;APAF1;HBXIP;CCNA1;IFNA12;TGFB1 |
| Measles | cgr2b;TRAF6;IFNAR2;RCHY1;MAVS;IFNG;Ifna15;TLR9;IFNB1 |
| Influenza A | MAP2K1;STAT2;HLA-DMA;NUP98;FDPS;IFNGR1;IFNA13;RAE1;BLA |
| Herpes simplex infection | TTC6;ARNTL;TP53;IRF3;NXF2;MCRS1;PPP1CB;TAF3;TAF10 |
IFNB1 has several biochemical functions, for example, chloramphenicol O-acetyltransferase activity, cytokine activity, type I interferon receptor binding. Some of the functions are cooperated with other proteins, some of the functions could acted by IFNB1 itself. We selected most functions IFNB1 had, and list some proteins which have the same functions with IFNB1. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| chloramphenicol O-acetyltransferase activity | |
| cytokine activity | IL9;IL1B;CLCF1;IFNE;BMP8B;GDF10B;IL21;Ifna11;SPAW |
| type I interferon receptor binding | Gm13290;IFNA4;Ifna11;IFNA5;GM13279;IFNA1;RNF207B;Ifnz;IFNB1 |
IFNB1 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with IFNB1 here. Most of them are supplied by our site. Hope this information will be useful for your research of IFNB1.
- Q&As
- Reviews
Q&As (5)
Ask a questionIFNB1 is generally not recommended for individuals with a history of hypersensitivity to interferons or other components of the drug. It should be used with caution in patients with certain pre-existing medical conditions.
IFNB1 is being investigated for its potential role in cancer treatment due to its immunomodulatory effects. Clinical trials are ongoing to evaluate its efficacy in various types of cancer.
Common side effects include flu-like symptoms, injection site reactions, and changes in blood cell counts. Serious side effects are rare but can include liver problems and allergic reactions.
IFNB1 is often administered through subcutaneous or intramuscular injections. The frequency and dosage depend on the specific condition being treated.
IFNB1 is also used in the treatment of certain viral infections, such as hepatitis B and C. It has antiviral properties that can inhibit viral replication.
Customer Reviews (3)
Write a reviewThe manufacturer not only ensures the provision of superior protein but also aids researchers with their solid technical support, offering the necessary resources to optimize experimental protocols.
the IFNB1 protein offers numerous advantages for researchers conducting trials due to its high quality and stability.
manufacturers or suppliers of proteins can play a crucial role in supporting researchers during trials.
Ask a Question for All IFNB1 Products
Required fields are marked with *
My Review for All IFNB1 Products
Required fields are marked with *
